MICHAEL BENKOWITZ Transaction History

Date Transaction Value Shares Traded Form
Nov 18 2024
SELL
Open market or private sale
$3,594,300 $359.43 p/Share
10,000
Nov 18 2024
BUY
Exercise of conversion of derivative security
$1,065,600 $106.56 p/Share
10,000
Nov 11 2024
SELL
Open market or private sale
$6,115,050 $407.67 p/Share
15,000
Nov 11 2024
BUY
Exercise of conversion of derivative security
$1,598,400 $106.56 p/Share
15,000
Nov 07 2024
SELL
Open market or private sale
$6,023,550 $401.57 p/Share
15,000
Nov 07 2024
BUY
Exercise of conversion of derivative security
$1,598,400 $106.56 p/Share
15,000
Nov 06 2024
SELL
Open market or private sale
$3,954,800 $395.48 p/Share
10,000
Nov 06 2024
BUY
Exercise of conversion of derivative security
$1,111,200 $111.12 p/Share
10,000
Nov 01 2024
SELL
Open market or private sale
$5,503,827 $374.41 p/Share
14,700
Nov 01 2024
BUY
Exercise of conversion of derivative security
$1,767,822 $120.26 p/Share
14,700
Aug 07 2024
SELL
Open market or private sale
$8,104,250 $324.17 p/Share
25,000
Aug 07 2024
BUY
Exercise of conversion of derivative security
$2,890,750 $115.63 p/Share
25,000
MB

Michael Benkowitz

PRESIDENT AND COO
Silver Spring, MD

Track Institutional and Insider Activities on UTHR

Follow UNITED THERAPEUTICS Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR